Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, fo
about
Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucomaTissue-based multiphoton analysis of actomyosin and structural responses in human trabecular meshwork.Exciting directions in glaucomaAnalyzing live cellularity in the human trabecular meshworkMetrics of the normal anterior sclera: imaging with optical coherence tomographyDexamethasone disrupts intercellular junction formation and cytoskeleton organization in human trabecular meshwork cells.Trabecular meshwork gene expression after selective laser trabeculoplastyLatrunculin B Reduces Intraocular Pressure in Human Ocular Hypertension and Primary Open-Angle Glaucoma.The trabecular meshwork in normal eyes and in exfoliation glaucomaAqueous humor phospholipids of DBA/2J and DBA/2J-Gpnmb(+)/SjJ mice.Rat, mouse, and primate models of chronic glaucoma show sustained elevation of extracellular ATP and altered purinergic signaling in the posterior eye.Substratum compliance regulates human trabecular meshwork cell behaviors and response to latrunculin B.Substratum stiffness and latrunculin B regulate matrix gene and protein expression in human trabecular meshwork cells.1α,25-Dihydroxyvitamin D(3) and its analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D(3) (2MD), suppress intraocular pressure in non-human primates.Ionic currents of human trabecular meshwork cells from control and glaucoma subjectsTechnical Brief: a novel strategy for enrichment of trabecular meshwork protease proteome.Advances in glaucoma treatment and management: outflow drugs.Substratum stiffness and latrunculin B modulate the gene expression of the mechanotransducers YAP and TAZ in human trabecular meshwork cells.Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.Role of microRNAs in the trabecular meshwork.Tissue-based imaging model of human trabecular meshworkRho-kinase inhibitors offer a new approach in the treatment of glaucoma.Control of outflow resistance by soluble adenylyl cyclase.Review of application of mass spectrometry for analyses of anterior eye proteome.The Trabecular Meshwork: A Basic Review of Form and FunctionThe Role of Nitric Oxide in the Intraocular Pressure Lowering Efficacy of Latanoprostene Bunod: Review of Nonclinical Studies.The Outflow Pathway: A Tissue With Morphological and Functional Unity.Predictors of Intraocular Pressure After Phacoemulsification in Primary Open-Angle Glaucoma Eyes with Wide Versus Narrower Angles (An American Ophthalmological Society Thesis).Partitioning of the aqueous outflow in rat eyes.Proteasome Inhibition Increases the Efficiency of Lentiviral Vector-Mediated Transduction of Trabecular Meshwork.Effect of Yoga-Based Ocular Exercises in Lowering of Intraocular Pressure in Glaucoma Patients: An Affirmative Proposition
P2860
Q26861763-357292B7-4FDA-40C5-8392-D8EA0999DCBBQ27348461-FFDF3FE3-B230-4C04-8318-5AECAC6EFB5FQ28542397-AD4AC0B0-9C0C-4AAF-8327-0D324A9C062CQ30534775-F759669B-94DA-4360-964B-82379761BF15Q30662319-44581255-D4BE-4A42-9F3B-3EF4F383D0AEQ33595155-0424062C-F9F5-455A-9DCE-799F3A3EF5C6Q33957981-63D5382A-7002-4FE4-822F-02673FBFEF8BQ34181305-2911AD71-B57C-49A0-B03E-433CBA240BAAQ35142336-38495125-D709-44F3-8141-F8BAEB74DD97Q35602723-9786EA87-C92D-4400-A5D0-B6ED20414611Q35629172-72298F1B-A0AC-4E6C-A502-92F5B657CE90Q35647353-14E8C5FC-CCE6-4178-BB7A-BC4133F07DD6Q35865463-0E468017-52BC-4D2C-A3D0-95C1EA1ECE6FQ36079723-45037616-A30C-4F9A-94F2-BF607D56EF4EQ36569542-37D5928B-EE23-412B-BDD4-BB1E414099BBQ36661620-B23F708C-6DAF-4155-AAB7-8704E34ABB8DQ36983331-DFA55E6A-78B5-4400-92AB-1DDBD3CDC5A0Q37079926-1D9CD0C3-B4B7-42C5-AB5E-340EA61BA2E1Q37627442-13C4021F-DE6F-46A8-8F13-9708662924E8Q37710668-2C7D0AC0-868F-4A46-9F2D-ACFB0BF25E1EQ37710716-82B63B62-EA0A-4859-841C-355BEA51323DQ38149325-1BD8E2D1-BFFF-4820-A452-955714304F9BQ38169748-BE7547BE-9C7E-4FFF-851D-7F03E21BB52BQ38219646-E037FF10-F8DE-4557-B1EC-2F20DC0A43BBQ38263876-12EA3979-AF8B-4377-AF86-98865B9DB980Q38637048-1088E21C-F330-471E-A703-A0F919C9BA15Q38692787-E9ACB79F-C104-4CA7-A8D7-797CBBD8360DQ45374883-B38EE4C2-167C-4A3C-A67C-271B2D323E7EQ46730025-919EFF61-4F49-42CE-978C-108F3FE4FC2DQ47552653-9E6FCEE0-36E5-4F8F-A0E5-3108EC7511D0Q58775409-F7EB83A3-E4B0-49F4-A690-1B85D9F25DC2
P2860
Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, fo
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Enhancing trabecular outflow b ...... how, recognizing the signs, fo
@ast
Enhancing trabecular outflow b ...... how, recognizing the signs, fo
@en
type
label
Enhancing trabecular outflow b ...... how, recognizing the signs, fo
@ast
Enhancing trabecular outflow b ...... how, recognizing the signs, fo
@en
prefLabel
Enhancing trabecular outflow b ...... how, recognizing the signs, fo
@ast
Enhancing trabecular outflow b ...... how, recognizing the signs, fo
@en
P2860
P1476
Enhancing trabecular outflow b ...... how, recognizing the signs, fo
@en
P2093
Paul L Kaufman
P2860
P356
10.1016/J.EXER.2007.10.007
P577
2007-10-26T00:00:00Z